Potential of Oral c-Abl Kinase Inhibitor Therapy

Research Research discussion
1

“Inhibikase Therapeutics Announces Publication Highlighting Mechanism of Disease and the Potential of Oral c-Abl Kinase Inhibitor Therapy for the Treatment of Parkinson’s Disease”

“Preclinical research and clinical safety and tolerability data supports continued development of IkT-148009 to potentially slow or halt progression of Parkinson’s disease”

https://seekingalpha.com/pr/18578244-inhibikase-therapeutics-announces-publication-highlighting-mechanism-of-disease-and-potential

2

https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28858

3

Seems promising, but, should we be confident that the animal models hold well to humans?

Do animal models for Parkinsons respond in a similar manner to that in humans for existing drugs? … I will have to research this.

1 Like